Albertsons reaches $774M opioid settlement with governments nationwide. Levin Papantonio attorneys part of the legal team driving pharmacy accountability.
Albertsons's stock was falling Tuesday after a sales miss and an announcement that the grocery-store chain has reached a $774 million settlement to resolve opioid-related claims.
Albertsons swung to a fourth-quarter loss fueled by a charge from a new opioid settlement set to resolve substantially all opioid-related claims brought against the company.
Albertsons forecast its annual sales below Wall Street estimates on Tuesday, pointing to pressure on demand from fierce competition with bigger rivals rolling out heavier discounts.
BOISE, Idaho--(BUSINESS WIRE)--Albertsons Cos. announced it has reached a $774 million settlement framework to resolve substantially all of the opioid-related claims.
BOISE, Idaho--(BUSINESS WIRE)--Albertsons Cos. announced its Board of Directors has declared an increased cash dividend for the first quarter of $0.17 per share of common stock.